400,000 to 500,000 new cases world wide of oral cancer are diagnosed and causes about 150,000 deaths per year. More than 60 percent of the patients are diagnosed with late stage (III or IV stage) disease, therefore, 5-year overall survival rate is as low as 50 percent. Stage I-II may have excellent cure rates with minor surgery and few functional sequelae, highlighting the necessity for early diagnosis and heightened awareness in dentists.
This course will overview tips of early oral cancer recognition and referral decision guides. Multidisciplinary management of oral cancer as well as treatment related oral complications will be discussed in the evidence-based manner. Learn the significance of oral cancer, its prevalence and overall survival.
Identify the most common risk factors for oral cancer.
Describe the most common clinical presentations of oral cancer.
Discuss treatment strategies.
Discuss most common complications of oral cancer treatment.
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Tribune Group designates this activity for 1 continuing education credits.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH.
Share on social media: